← Back to guidelines
Cardiology4 papers

Infectious disease of central nervous system

Last edited: 4/22/2026

Overview

Infectious diseases affecting the central nervous system (CNS) encompass a range of conditions caused by pathogens such as bacteria, viruses, fungi, and parasites, leading to significant neurological morbidity and mortality 1.

Diagnosis

  • Clinical Presentation: Fever, altered mental status, focal neurological deficits, seizures 1.
  • Laboratory Tests: CSF analysis (pleocytosis, elevated protein, low glucose), blood cultures 1.
  • Imaging: MRI or CT scans to identify lesions or inflammation 1.
  • Microbiological Confirmation: PCR, culture, serology specific to suspected pathogens 1.
  • Management

  • Antibiotics: For bacterial meningitis, e.g., ceftriaxone or vancomycin (doses vary by pathogen and patient condition) 1.
  • Antivirals: Acyclovir for herpes simplex virus encephalitis 1.
  • Adjunctive Therapies: Corticosteroids to reduce inflammation (e.g., dexamethasone) 1.
  • Supportive Care: Fluid management, anticonvulsants, intensive care monitoring 1.
  • Special Populations

  • Pregnancy: Careful selection of antibiotics to avoid fetal toxicity; consider acyclovir for viral encephalitis 1.
  • Pediatrics: Higher vigilance for atypical presentations; tailored dosing of medications 1.
  • Elderly: Increased risk of complications; close monitoring for cognitive decline and sepsis 1.
  • Comorbidities: Tailor treatment based on underlying conditions; manage immunosuppression carefully 1.
  • Key Recommendations

  • Utilize broad-spectrum antibiotics early in suspected bacterial meningitis until culture results guide specific therapy (Evidence: Strong 1).
  • Consider corticosteroid use in bacterial meningitis to reduce mortality and morbidity (Evidence: Moderate 1).
  • Select antiviral therapy based on suspected pathogen; acyclovir is recommended for herpes simplex virus encephalitis (Evidence: Moderate 1).
  • References

    1 Ashayeri Ahmadabad H, Mohammadi Panah S, Ghasemnejad-Berenji H, Ghojavand S, Ghasemnejad-Berenji M, Khezri MR. Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases. Naunyn-Schmiedeberg's archives of pharmacology 2025. link

    Original source

    1. [1]
      Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases.Ashayeri Ahmadabad H, Mohammadi Panah S, Ghasemnejad-Berenji H, Ghojavand S, Ghasemnejad-Berenji M, Khezri MR Naunyn-Schmiedeberg's archives of pharmacology (2025)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG